Steurer MA, Jelliffe-Pawlowski LL, Baer RJ, Partridge JC, Rogers EE, Keller RL. Persistent Pulmonary Hypertension of the Newborn in Late Preterm and Term Infants in California. Pediatrics. 2017;139:2016–1165.
Hernández-Díaz S, Van Marter LJ, Werler MM, Louik C, Mitchell AA. Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics. 2007;120:e272–82.
Dempsey EM, Barrington KJ. Diagnostic criteria and therapeutic interventions for the hypotensive very low birth weight infant. J Perinatol. 2006;26:677–81.
Article CAS PubMed Google Scholar
Stark A, Smith PB, Hornik CP, Zimmerman KO, Hornik CD, Pradeep S, et al. Medication use in the neonatal intensive care unit and changes from 2010 to 2018. J Pediatr. 2022;240:66–71.e4.
Sharman A, Low J Vasopressin and its role in critical care. Continuing Education in Anaesthesia Critical Care & Pain 2008;8:134–7.
Schneider EG. Effect of vasopressin on adrenal steroidogenesis. Am J Physiol. 1988;255:R806–11.
Meyer S, Gortner L, McGuire W, Baghai A, Gottschling S. Vasopressin in catecholamine-refractory shock in children. Anaesthesia. 2008;63:228–34.
Article CAS PubMed Google Scholar
Kaga M, Matsuda T, Watanabe T, Onodera S, Watanabe S, Usuda H, et al. Renal vasodilatory action of arginine vasopressin in extremely low birth weight infants. Tohoku J Exp Med. 2013;231:159–64.
Article CAS PubMed Google Scholar
Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest. 2001;120:989–1002.
Article CAS PubMed Google Scholar
Evora PR, Pearson PJ, Schaff HV. Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide. Chest. 1993;103:1241–5.
Article CAS PubMed Google Scholar
Wallace AW, Tunin CM, Shoukas AA. Effects of vasopressin on pulmonary and systemic vascular mechanics. Am J Physiol. 1989;257:H1228–34.
Mohamed A, Nasef N, Shah V, McNamara PJ. Vasopressin as a rescue therapy for refractory pulmonary hypertension in neonates: case series. Pediatr Crit Care Med. 2014;15:148–54.
Polito A, Parisini E, Ricci Z, Picardo S, Annane D. Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis. Intensive Care Med. 2012;38:9–19.
Article CAS PubMed Google Scholar
Obritsch MD, Bestul DJ, Jung R, Fish DN, MacLaren R. The role of vasopressin in vasodilatory septic shock. Pharmacotherapy. 2004;24:1050–63.
Article CAS PubMed Google Scholar
John A, Yeh C, Boyd J, Greilich PE. Treatment of refractory hypotension with low-dose vasopressin in a patient receiving clozapine. J Cardiothorac Vasc Anesth. 2010;24:467–8.
Ikegami H, Funato M, Tamai H, Wada H, Nabetani M, Nishihara M. Low-dose vasopressin infusion therapy for refractory hypotension in ELBW infants. Pediatr Int. 2010;52:368–73.
Article CAS PubMed Google Scholar
Bidegain M, Greenberg R, Simmons C, Dang C, Cotten CM, Smith PB. Vasopressin for refractory hypotension in extremely low birth weight infants. J Pediatr. 2010;157:502–4.
Article PubMed PubMed Central Google Scholar
Budniok T, ElSayed Y, Louis D. Effect of vasopressin on systemic and pulmonary hemodynamics in neonates. Am J Perinatol. 2021;38:1330–4.
McIntosh AM, Tong S, Deakyne SJ, Davidson JA, Scott HF. Validation of the vasoactive-inotropic score in pediatric sepsis. Pediatr Crit Care Med. 2017;18:750–7.
Article PubMed PubMed Central Google Scholar
Acker SN, Kinsella JP, Abman SH, Gien J. Vasopressin improves hemodynamic status in infants with congenital diaphragmatic hernia. J Pediatr. 2014;165:53–8.e1.
Article CAS PubMed PubMed Central Google Scholar
Ni M, Kaiser JR, Moffett BS, Rhee CJ, Placencia J, Dinh KL, et al. Use of Vasopressin in Neonatal Intensive Care Unit Patients With Hypotension. J Pediatr Pharm Ther. 2017;22:430–5.
Arruda JA, Stipanuk S, Walter R, Kurtzman NA.Effect of vasopressin administration on sodium excretion and plasma phosphate concentration.Proc Soc Exp Biol Med. 1977;155:308–13.
Comments (0)